Question 1

Which of the following drug classes is contraindicated in pregnancy and requires LFT baseline lab monitoring prior to use:

Accepted Answer

HMG CoA Reductase Inhibitors - Monitor Ck in patients ONLY if they have muscle complaints (Rhabdo)

Question 2

A patient with an LDL of 225 on the max dose of Atorvastatin is prescribed Ezetimibe as an adjunct. What percentage of thier LDL should be expected to decrease with this therapy?

Accepted Answer

18-23% - **Avoid in severe hepatic insufficiency**

Question 3

This adjunt therapy is given subcutaneously every 2-4 weeks in patients who require additional decrease of thier LDL or are intolerant to statin therapy

Accepted Answer

Alirocumab  - PCSK9i

Question 4

A patient using simvastatin to lower thier LDL should avoid use of this medication

Accepted Answer

Gemfibrozil

Question 5

Which of the following is not considered a high intensity statin:

Accepted Answer

Rosuvastatin 10mg

Question 6

Which of the following AE is most commonly seen in patients using Niacin to reduce thier triglycerides?

Accepted Answer

Intense Flushing - Niacin reduces triglycerides by 20-50% and is the MOST EFFECTIVE for lNCREASING HDL

Question 7

Your patient is a  65 y/o woman with no PMH, a 16% ASCVD risk and an LDL of 180. What medication should you prescribe?

Accepted Answer

Simvastatin 20mg

Question 8

What treatment option would be best for a 52 y/o patient with T2DM, LDL of 191 and a 12.5% ASCVD risk

Accepted Answer

Atorvastatin 40mg - high intensity statin

Question 9

How much should a high intensity statin be expected to lower LDL in compliant patients?

Accepted Answer

>50%

Question 10

Which of the following patients would not meet the criteria for use of a high intensity statin regimen:

Accepted Answer

A 65 y/o T2DM patient with no ASCVD risk - This patient would use a moderate statin unless other risks develop

Question 11

Which of the following labs is most appropriate to order prior to starting a patient on a statin?

Accepted Answer

LFTs

Question 12

A 60-year-old man presents to clinic with a PMH of ASCVD. You review his lipid panel which reveals an LDL 90. Which of the following is the most appropriate treatment

Accepted Answer

Rosuvastatin 20mg

Patient Management - Hyperlipidemia - Test Review

2) A patient with an LDL of 225 on the max dose of Atorvastatin is prescribed Ezetimibe as an adjunct. What percentage of thier LDL should be expected to decrease with this therapy?

3) This adjunt therapy is given subcutaneously every 2-4 weeks in patients who require additional decrease of thier LDL or are intolerant to statin therapy

4) A patient using simvastatin to lower thier LDL should avoid use of this medication

5) Which of the following is not considered a high intensity statin:

6) Which of the following AE is most commonly seen in patients using Niacin to reduce thier triglycerides?

7) Your patient is a 65 y/o woman with no PMH, a 16% ASCVD risk and an LDL of 180. What medication should you prescribe?

8) What treatment option would be best for a 52 y/o patient with T2DM, LDL of 191 and a 12.5% ASCVD risk

9) How much should a high intensity statin be expected to lower LDL in compliant patients?

10) Which of the following patients would not meet the criteria for use of a high intensity statin regimen:

11) Which of the following labs is most appropriate to order prior to starting a patient on a statin?

12) A 60-year-old man presents to clinic with a PMH of ASCVD. You review his lipid panel which reveals an LDL 90. Which of the following is the most appropriate treatment